Multi-omic characterization of acquired resistance to immune checkpoint inhibitors in patients with metastatic renal cell carcinoma.

被引：1
|
作者：
Saad, Eddy
Labaki, Chris
Miron, Benjamin
Park, Jihye
Bakouny, Ziad
Nassar, Amin
Saliby, Renee Maria
Semaan, Karl
Eid, Marc
Meli, Kevin
Laimon, Yasmin Nabil
Geynisman, Daniel M.
Kokate, Rutika
Braun, David A.
Signoretti, Sabina
Mcgregor, Bradley Alexander
Plimack, Elizabeth R.
Choueiri, Toni K.
Van Allen, Eliezer Mendel
Zibelman, Matthew R.
机构：
[1] Dana Farber Canc Inst, Boston, MA USA
[2] Beth Israel Deaconess Med Ctr, Boston, MA USA
[3] Fox Chase Canc Ctr, Philadelphia, PA USA
[4] Mem Sloan Kettering Canc Ctr, New York, NY USA
[5] Yale Canc Ctr, New Haven, CT USA
[6] Harvard Univ, Cambridge, MA USA
[7] Brigham & Womens Hosp, Boston, MA USA
[8] Yale Univ, New Haven, CT USA
[9] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA
[10] Fox Chase Canc Ctr, Temple Hlth, Philadelphia, PA USA
[11] Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
283-2494-9200; 3282-206-3691-5663-4986; 613-225-3248-9559-9794; 3282-206-3691-2722-5055; 3282-646-4685-2628; 5; 3; 2; 38092-18323; 38092-27449; 38092-23384;
D O I：
10.1200/JCO.2024.42.4_suppl.459
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Checkpoint Inhibitors in Patients With Metastatic Renal Cell Carcinoma: Results From the International Metastatic Renal Cell Carcinoma Database Consortium
    Yip, Steven M.
    Wells, Connor
    Moreira, Raphael
    Wong, Alex
    Srinivas, Sandy
    Beuselinck, Benoit
    Porta, Camillo
    Sim, Hao-Wen
    Ernst, D. Scott
    Rini, Brian I.
    Yuasa, Takeshi
    Basappa, Naveen S.
    Kanesvaran, Ravindran
    Wood, Lori A.
    Canil, Christina
    Kapoor, Anil
    Fu, Simon Y. F.
    Choueiri, Toni K.
    Heng, Daniel Y. C.
    CANCER, 2018, 124 (18) : 3677 - 3683
  • [32] ACTIVATION OF STAT3 SIGNALING IS ASSOCIATED WITH RESISTANCE TO IMMUNE CHECKPOINT INHIBITORS IN PATIENTS (PTS) WITH METASTATIC RENAL CELL CARCINOMA (MRCC)
    Chehrazi-Raffle, Alexander
    Alcantara, Marice
    Dizman, Nazli
    Tang, Wilson
    Meza, Luis
    Zengin, Zeynep
    Wang, Dongfang
    Moreira, Dayson
    Castro, Daniela
    Govindarajan, Ameish
    Horsager, Alan
    Hsu, JoAnn
    Pal, Sumanta
    Kortylewski, Marcin
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A917 - A917
  • [33] Biomarkers for Immune Checkpoint Inhibitors in Renal Cell Carcinoma
    Martin, Spencer D. D.
    Bhuiyan, Ishmam
    Soleimani, Maryam
    Wang, Gang
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (15)
  • [34] Editorial: Immune checkpoint inhibitors in renal cell carcinoma
    Tykodi, Scott S. S.
    Pichler, Renate
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [35] Immune Checkpoint Inhibitors in the Treatment of Renal Cell Carcinoma
    Parikh, Mamta
    Bajwa, Poornima
    SEMINARS IN NEPHROLOGY, 2020, 40 (01) : 76 - 85
  • [36] Treatment Decisions for Metastatic Clear Cell Renal Cell Carcinoma in Older Patients: The Role of TKIs and Immune Checkpoint Inhibitors
    John Esther
    Peter Hale
    Andrew W. Hahn
    Neeraj Agarwal
    Benjamin L. Maughan
    Drugs & Aging, 2019, 36 : 395 - 401
  • [37] Treatment Decisions for Metastatic Clear Cell Renal Cell Carcinoma in Older Patients: The Role of TKIs and Immune Checkpoint Inhibitors
    Esther, John
    Hale, Peter
    Hahn, Andrew W.
    Agarwal, Neeraj
    Maughan, Benjamin L.
    DRUGS & AGING, 2019, 36 (05) : 395 - 401
  • [38] Adding Cyclooxygenase Inhibitors to Immune Checkpoint Inhibitors Did Not Improve Outcomes in Metastatic Renal Cell Carcinoma
    Zhang, Yumeng
    Kumar, Premsai
    Adashek, Jacob J.
    Skelton, William P.
    Li, Jiannong
    Vosoughi, Aram
    Chahoud, Jad
    Manley, Brandon J.
    Spiess, Philippe E.
    CELLS, 2022, 11 (16)
  • [39] ASSOCIATION OF IMMUNE RELATED ADVERSE EVENTS WITH THE EFFICACY OF IMMUNE CHECKPOINT INHIBITORS IN METASTATIC RENAL CELL CARCINOMA
    Bushunow, Vasilii
    Appleman, Leonard
    Thomas, Roby
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A112 - A113
  • [40] Integrative tumor and immune cell multi-omic analyses to predict melanoma response to immune checkpoint blockade.
    Anagnostou, Valsamo
    Bruhm, Daniel C.
    Niknafs, Noushin
    White, James R.
    Sidhom, John-William
    Stein, Julie E.
    Tsai, Hua-Ling
    Wang, Hao
    Belcaid, Zineb
    Murray, Joseph Christopher
    Ross-Macdonald, Petra B.
    Wind-Rotolo, Megan
    Baras, Alexander S.
    Taube, Janis M.
    Scharpf, Robert B.
    Grasso, Catherine
    Ribas, Antoni
    Pardoll, Drew M.
    Topalian, Suzanne Louise
    Velculescu, Victor E.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345